Baylor St. Luke’s Medical Center in Texas adopts our Sentimag localisation system
Two of their prominent surgical oncologists, Dr. Alastair Thompson and Dr. Stacey Carter, were the first breast surgeons in the southern U.S. to use both of our cancer marking technologies together in a procedure.
When speaking to expert physicians, we often hear that improving patient care is one of the biggest factors that motivates them to take the leap and change how they practice surgery. A common way we see this is by improving the technology they use.
One of the top cancer centres in the US, Baylor St. Luke’s Medical Center in Texas, has recently shared the news of their technology upgrade for breast surgery, also featured by Texas Medical Center News. They've made the switch from guide wires for tissue localisation and radioactive tracers for sentinel node biopsy procedures, to now using our wire-free, radiation-free localisation system.
Two of their prominent surgical oncologists, Dr. Alastair Thompson and Dr. Stacey Carter, were the first breast surgeons in the southern US to use our Sentimag® platform with both of our cancer marking technologies, Magseed® and Magtrace®, during surgery for invasive breast cancer.
An infographic from CHI St. Luke's shows some of the differences in their traditional methods versus our new technologies:
They had recognised that better screening programmes had meant that breast cancers are routinely being detected earlier and smaller than before. And while they are masters of the traditional methods of surgery, they saw an opportunity for improvement.
Their upgrade could not only increase accuracy for localising earlier-stage cancers, but also limit unneeded exposure to radiation.
CHI St. Luke’s Medical Center commented: “this system can improve the accuracy of surgery, increasing the likelihood that doctors will remove the tumor in one piece while preserving as much healthy tissue as possible.”
We're thrilled to see more hospitals recognise the benefits that our technologies can provide to both patients and hospitals.